Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients

Donor-derived cell-free DNA (dd-cfDNA) has been of major interest recently as a non-invasive marker of graft injury, but has not yet been extensively tested in children. From May to September in 2019, a total of 76 pediatric patients receiving a liver graft were enrolled and there were 27 patients e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dong, Zhou, Tao, Luo, Yi, Wu, Cheng, Xu, Dongwei, Zhong, Chengpeng, Cong, Wenming, Liu, Qiang, Zhang, Jianjun, Xia, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807012/
https://www.ncbi.nlm.nih.gov/pubmed/33441886
http://dx.doi.org/10.1038/s41598-020-80845-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807012/
https://www.ncbi.nlm.nih.gov/pubmed/33441886
http://dx.doi.org/10.1038/s41598-020-80845-6

Ejemplares similares